NCT04284891

Brief Summary

Premature birth is the leading cause of death in children younger than 5 years old worldwide, especially in low- and middle-income countries. Premature infants who survive are at greater risk of a range of short-term and long-term health consequences. Common long-term health morbidities among children who are born prematurely include cerebral palsy, infections (particularly respiratory infections), bronchopulmonary dysplasia, feeding difficulties, hypoxic-ischemic encephalopathy, visual and hearing problems. Re-hospitalization occurs frequently during first few years of life among ex-premature infants with respiratory illness. This leads to increased financial burden for health care system and families. The impact of prematurity on the health care system, especially on pediatric intensive care units (PICUs) has mainly been evaluated in high income countries. Little is known about long term health outcomes of ex-premature infants and their impact on the cost to health care system in low- and middle-income countries. This pilot, single institution, observational study aims to determine the prevalence, course of the diseases, and outcomes of ex-premature infants with respiratory illnesses who are admitted to a PICU of a tertiary children's hospital in Vietnam. Investigators will determine the epidemiology of respiratory illness, and the resource utilization for these children in the PICU. To achieve these aims, the investigators will prospectively screen and recruit all children aged less than 2 years old admitted to the PICU with respiratory illness/failure and collect pertinent clinical data. The study participants will be follow-up until PICU discharge.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
202

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 21, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

November 1, 2019

Completed
4 months until next milestone

First Posted

Study publicly available on registry

February 26, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2021

Completed
Last Updated

May 2, 2022

Status Verified

April 1, 2022

Enrollment Period

1.6 years

First QC Date

September 21, 2019

Last Update Submit

April 29, 2022

Conditions

Keywords

Respiratory Diseases, ex-prematurityRespiratory FailurePediatric Intensive Care

Outcome Measures

Primary Outcomes (2)

  • Percentage of ex-premature infants aged < 2 years admitted to Pediatric Intensive Care Unit (PICU)

    The percentage of ex-premature patients to the total number of patients aged ≤ 2 years age admitted to PICU over a defined period

    Through study completion, an average of 1 year

  • Percentage of ex- premature infants aged < 2 years admitted to PICU with critical respiratory diseases.

    The percentage of ex-premature patients to the total number of patients aged ≤ 2 years age with respiratory illness admitted to PICU over a defined period

    Through study completion, an average of 1 year

Secondary Outcomes (7)

  • Percentage of identified pathogens of critical respiratory diseases among study participants

    Up to 60 days

  • Number of participants with all-cause mortality

    Up to 60 days

  • Time from start to end of mechanical ventilation

    Up to 60 days

  • Time from pediatric intensive care unit (PICU) admission to PICU discharge

    Up to 60 days

  • Percentage of participants receiving mechanical ventilation support

    Up to 60 days

  • +2 more secondary outcomes

Eligibility Criteria

Age30 Days - 2 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

All patients aged ≤ 2 year olds with respiratory diseases

You may qualify if:

  • All patients aged ≤ 2 year olds with respiratory diseases admitted to pediatric intensive care unit of Vietnam National Children's Hospital

You may not qualify if:

  • Nil

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vietnam National Children's Hospital

Hanoi, Vietnam

Location

MeSH Terms

Conditions

Infant, Premature, DiseasesRespiration DisordersRespiratory InsufficiencyPremature BirthRespiratory Tract Diseases

Condition Hierarchy (Ancestors)

Infant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Phuc H Phan, MD

    Vietnam National Children's Hospital

    PRINCIPAL INVESTIGATOR
  • Jan Hau Lee, MD

    Duke-NUS Medical, Singapore

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Deputy Director of Pediatric Intensive Care Unit

Study Record Dates

First Submitted

September 21, 2019

First Posted

February 26, 2020

Study Start

November 1, 2019

Primary Completion

May 30, 2021

Study Completion

May 30, 2021

Last Updated

May 2, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations